Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model

Tappenden, P. orcid.org/0000-0001-6612-2332, Carroll, C. orcid.org/0000-0002-6361-6182, Hamilton, J. orcid.org/0000-0003-3326-9842 et al. (5 more authors) (2019) Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model. Health Technology Assessment, 23 (8). pp. 1-144. ISSN 1366-5278

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Queen’s Printer and Controller of HMSO 2019. Reproduced in accordance with the publisher's self-archiving policy.
Keywords: Economic; models; network meta-analysis; thyroid neoplasms
Dates:
  • Published (online): 1 February 2019
  • Published: 1 March 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 08 Mar 2019 10:21
Last Modified: 08 Mar 2019 10:21
Published Version: https://doi.org/10.3310/hta23080
Status: Published
Publisher: NIHR Journals Library
Refereed: Yes
Identification Number: https://doi.org/10.3310/hta23080
Related URLs:

Share / Export

Statistics